Holen Sie sich die Stockscreener-App
5.69
0.53%
0.03
Schlusskurs vom Vortag:
$5.66
Offen:
$5.65
24-Stunden-Volumen:
53,273
Relative Volume:
0.03
Marktkapitalisierung:
$10.22M
Einnahmen:
$9.26M
Nettoeinkommen (Verlust:
$-941.60K
KGV:
-79.03
EPS:
-0.072
Netto-Cashflow:
$-2.65M
1W Leistung:
-1.39%
1M Leistung:
-14.31%
6M Leistung:
+73.85%
1J Leistung:
+31.53%
1-Tages-Spanne:
$5.53
$5.72
1-Wochen-Bereich:
$5.53
$5.81
52-Wochen-Spanne:
$2.0068
$15.60
Bionexus Gene Lab Corp Stock (BGLC) Company Profile
Firmenname
Bionexus Gene Lab Corp
Sektor
Branche
Telefon
1-307-241-6898
Adresse
10-2 TOWER B, VERTICAL BUSINESS SUITE,, KUALA LUMPUR
Vergleichen Sie BGLC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BGLC
BioNexus Gene Lab Corp Common stock
|
0.343 | 201.51M | 0 | 0 | 0 | 0.00 |
|
MOBBW
Mobilicom Limited Warrants
|
1.40 | 2.19B | 0 | 0 | 0 | 0.00 |
|
GOODO
Gladstone Commercial Corporation
|
20.45 | 372.90M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
2.41 | 111.01M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
0.3762 | 672.88M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
DAVEW
Dave Inc
|
1.1699 | 0 | 0 | 0 | 0 | 0.00 |
Bionexus Gene Lab Corp Aktie (BGLC) Neueste Nachrichten
What’s the outlook for BioNexus Gene Lab Corp.’s sectorPortfolio Profit Report & High Return Stock Watch Alerts - khodrobank.com
Is it time to cut losses on BioNexus Gene Lab Corp.Portfolio Risk Summary & Growth Focused Entry Point Reports - Newser
Real time breakdown of BioNexus Gene Lab Corp. stock performanceExit Point & Weekly High Return Opportunities - Newser
Analyzing drawdowns of BioNexus Gene Lab Corp. with statistical toolsJuly 2025 Highlights & Expert Approved Momentum Ideas - Newser
Has BioNexus Gene Lab Corp. formed a bullish divergenceMarket Activity Report & Stepwise Entry and Exit Trade Signals - Newser
Ranking BioNexus Gene Lab Corp. among high performing stocks via toolsExit Point & Fast Gaining Stock Strategy Reports - Newser
Relative strength of BioNexus Gene Lab Corp. in sector analysisJuly 2025 PostEarnings & Community Consensus Trade Alerts - Newser
Short interest data insights for BioNexus Gene Lab Corp.Weekly Trading Summary & Stock Portfolio Risk Management - Newser
BioNexus Gene Lab Corp. stock volume spike explainedJuly 2025 Rallies & Stock Timing and Entry Methods - Newser
Applying Wyckoff theory to BioNexus Gene Lab Corp. stockJuly 2025 PreEarnings & Intraday High Probability Setup Alerts - Newser
Is BioNexus Gene Lab Corp. a candidate for recovery playMarket Performance Report & Verified Short-Term Plans - Newser
Is BioNexus Gene Lab Corp. forming a reversal patternJobs Report & Accurate Technical Buy Alerts - Newser
Measuring BioNexus Gene Lab Corp.’s beta against major indices2025 Short Interest & Daily Technical Stock Forecast Reports - Newser
Exit strategy if you’re trapped in BioNexus Gene Lab Corp.Gap Down & Verified Stock Trade Ideas - Newser
Can volume confirm reversal in BioNexus Gene Lab Corp.Market Activity Report & High Accuracy Investment Signals - Newser
Will BioNexus Gene Lab Corp. stock recover after earningsTrend Reversal & Real-Time Stock Entry Alerts - khodrobank.com
Is BioNexus Gene Lab Corp. stock a good dividend stockJuly 2025 Fed Impact & Consistent Growth Equity Picks - khodrobank.com
Historical volatility pattern of BioNexus Gene Lab Corp. visualizedQuarterly Trade Summary & Advanced Swing Trade Entry Alerts - Newser
Published on: 2025-09-01 21:07:02 - Newser
Multi factor analysis applied to BioNexus Gene Lab Corp.Weekly Trend Summary & Weekly Watchlist for Consistent Profits - Newser
Key metrics from BioNexus Gene Lab Corp.’s quarterly dataTrade Entry Summary & Verified Short-Term Trading Plans - Newser
Visualizing BioNexus Gene Lab Corp. stock with heatmapsPortfolio Value Summary & Safe Capital Growth Stock Tips - Newser
Detecting support and resistance levels for BioNexus Gene Lab Corp.Exit Point & Smart Investment Allocation Insights - Newser
Market reaction to BioNexus Gene Lab Corp.’s recent newsTrade Risk Assessment & Growth Oriented Trading Recommendations - Newser
Is this a good reentry point in BioNexus Gene Lab Corp.2025 Top Gainers & AI Enhanced Execution Alerts - Newser
Is it too late to sell BioNexus Gene Lab Corp.July 2025 Reactions & Safe Capital Preservation Plans - Newser
Is BioNexus Gene Lab Corp. stock entering bullish territoryTrade Volume Report & Low Risk High Win Rate Stock Picks - Newser
Finanzdaten der Bionexus Gene Lab Corp-Aktie (BGLC)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.53%
0.27%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):